Transforming your biologic development process

Accelerating the journey of your new biologic from the lab to market can give you a competitive advantage.  Over the past 10 years, global demand for biologics has increased to 42% of the total clinical pipeline, and the challenges, risks and costs of bringing complex large molecule products to market are growing exponentially. Time is of the essence to unleash the potential of your new product. 

During this webinar, you will hear from Gergő Nagy, Senior Sales Specialist at Thermo Fisher and Elena Gontarz, Sr Manager, R&D Projects at Thermo Fisher pharma services, on how Thermo Fisher Scientific is supporting new and emerging biotechs to get to clinic and to market, faster. No longer viewed as transactional service providers, CDMOs are an integral part of the pharmaceutical supply chain, and collaboration is foundational to the drug sponsors’ success. 

    Key topics:
    • How we bolster our supply chain, harmonizing materials and processes, dual supply and regional sourcing for raw materials, such as buffers, process liquids and cGMP chemicals, helping shorten lead times 
    • How we reduce complexity to help bring your molecule to clinic with increased speed with Patheon™ Quick to Clinic™ for biologics - balancing early development timelines, risks, future scale-up and commercialization needs

Speakers:

Elena Gontarz

Senior Manager of Scientific and Technical Affairs

Thermo Fisher Scientific

Elena is a Cell Line, Process, and Analytical Development SME with 8 years of pharma industry relevant experience. She earned her PhD in Biochemistry from University of Missouri – St. Louis in 2014. Following graduation, Elena joined Analytical Development and Formulation Sciences Group in Patheon biologics, where she acquired working knowledge of analytical method life cycle from Phase I to commercial manufacturing. Areas of expertise are and not limited to Analytical Method development, transfer, qualification, and validation, as well as product comparability and Phase III forced degradation studies. In the last 3 years, Elena was heavily cross-trained around Cell Line & Process Development, in addition to recieving CMC certification. While as a Senior Manager, Scientific and Technical Affairs team, Elena is providing CMC support for Clients and the Commercial Development Group, as well as leading technical and business offering development projects within Thermo Fisher Scientific.

Gergő Z. Nagy

Senior Technical Sales Specialist

Gergő Z. Nagy is a Sr. Technical Sales Specialist, and former Scientist,  working in Central Europe with over 10 years of experience in the life science industry. He earned his M.Sc Chemistry from University of Debrecen in Hungary. Gergő brings unique perspectives gained from his academic field experience to your organization, empowering you to unleash the untapped potential within your Bioproduction processes. Gergő is passionate about using real-world examples he has garnered working closely with small to large Biopharma customers. Helping to shed light on the critical need to bolster your supply chain and harmonize your cGMP chemicals, process liquids and buffers with Thermo Fisher Scientific, to positively impact your mission and molecule development.

Hosted by

Maire Gerrard

Managing Editor, Custom Content

Pharma Intelligence

Complete the form to register for this webinar!

I would like Thermo Fisher Scientific group (thermofisher.com/legalentities) to add me to a list to receive information events, products, services and promotions which Thermo Fisher believes may be of interest to me via the following channels:


I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com.
By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio

By completing this you acknowledge Thermo Fisher Scientific (including its affiliates) will process my Personal Information according to its  privacy policy, which includes information about my rights, and that Pharma Intelligence may contact you directly about industry news, products, services and events that may be of interest subject to Pharma Intelligence UK Ltd’s privacy policy.